An analysis of ctDNA testing for early detection of recurrence showed that test had high sensitivity across multiple sites of ...

Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefited from first-line treatment with the ...

Pfizer Inc. (NYSE:PFE) revealed results from the Phase 3 BREAKWATER trial evaluating Braftovi (encorafenib) in combination ...

Researchers have discovered how a particular protein affects the growth and spread of colon cancer in humans. The study not ...

A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham ...

SAN DIEGO and SUZHOU, China - Adagene Inc. (NASDAQ: ADAG), a biotechnology firm with a market capitalization of $85 million ...

Aspirin did not provide any clinical benefits in a cohort of patients with colorectal cancer who had no history of cardiovascular disease or stroke.

Bristol Myers Squibb’s Opdivo plus Yervoy, as well as Pfizer’s Braftovi, have each shown strong Phase III performances that ...

Inhibitory effect escalating concentration of A. herba-alba extract on cell viability of various colon cancer cell lines after (A) 24 h and (B) 48 ...

James Van Der Beek thanked his father for guiding him physically and emotionally through his colorectal cancer diagnosis in a ...

Natera has reported the latest data from the Phase III CALGB (Alliance)/SWOG 80702 study, indicating that Signatera, a ...

Barry Stein had ignored symptoms that started appearing in 1995, until he was diagnosed with stage four colorectal cancer.